Experience
Biogen International GmbH
Teva Pharmaceuticals USA, Inc.
Represented Biogen in a Hatch-Waxman litigation involving 28 companies seeking FDA approval to market generic versions of Tecfidera®.
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc., 1:17-cv-00829, D. Del., Judge Noreika
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc., 1:17-cv-00116, N.D.W. Va., Judge Keeley
Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC et al.
Biogen Int’l GmbH
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Pronova Biopharma Norge AS
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Eli Lilly and Company
Tenneco Inc.
Grünenthal GmbH v. Teva Pharmaceuticals
Grünenthal GmbH
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.